IP Verse

Dry Powder Inhalation Drug Products Exhibiting Moisture Control Properties And Methods Of Administering The Same - EP3461474

PATENT ANALYSIS

Patent Details

Grant Date
Nov 11, 2020
Company
GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Oppositions

GENERICS [UK] LIMITED

HGF LIMITED

SANDOZ AG

TEVA UK LIMITED

More patents of Glaxosmithkline Intellectual Property Development Limited

EP3650019

EP3297605

EP3461474

Want to monitor this patent?

Feel free to send us a message here and we will get back to you